Skip to content Skip to footer
Menu Close
Close
Vaccines

Help Advance Flu Prevention Research for Adults 65 and Older by Joining Influenza Vaccine Clinical Trials.

 Influenza vaccine research study

Flu Clinical Trials in Los Angeles

As we age, the risk of serious complications from influenza can increase, making prevention more important than ever. By participating in research, you can help scientists better understand how vaccines perform in older adults and support the development of future prevention strategies.

Zillan Clinical Research is conducting Phase 3/3b Influenza vaccine clinical trials comparing two influenza vaccines to evaluate their effectiveness, safety, and immune response in adults aged 65 years and older. Eligible participants may receive study-related care, health assessments, study vaccination, and follow-up monitoring at no cost while contributing to important medical research.

See if You Are Eligible to Participate
About This Study

Exploring Better Ways to Protect Against Seasonal Flu

The current Influenza vaccine clinical trials at Zillan Clinical Research are evaluating the safety, effectiveness, and immune response of an investigational vaccine compared with a standard influenza vaccine in adults aged 65 years and older. Participants will receive either the study vaccine or a comparison vaccine and will be monitored through scheduled visits and health assessments throughout the study.

As part of this Flu vaccine study, participants should not have received investigational medications or vaccines within the previous 30 days and should not have received blood products or immunoglobulins within the past 180 days. These requirements help ensure participant safety and the accuracy of study results.

Now Enrolling

Current Status

Influenza

Condition
Partner With Us
Our Values

Why Patients Trust Us

At Zillan Clinical Research, we believe every participant plays an important role in advancing healthcare. It all starts with You!

Experienced Research Physicians

Providing hands-on oversight and guidance throughout every stage of the study.

Advanced Vaccine Research

Supporting innovative vaccine development through well-designed Phase I–IV clinical trials.

Quality You Can Trust

Conducting every study under rigorous quality standards and regulatory requirements.

Global Research Impact

Partnering with leading healthcare innovators to help bring future treatments and vaccines closer to reality.

Personalized Participant Support

Ensuring every participant feels informed, comfortable, and supported throughout the research journey.

Safety at Every Step

Following ICH, GCP, and regulatory guidelines with continuous safety monitoring and oversight.

FAQ

Frequently Asked Questions

Influenza vaccine clinical trials are research studies designed to evaluate how well vaccines help protect against seasonal influenza while assessing safety and immune response.

Adults aged 65 years and older may qualify, depending on their medical history and other study requirements.

This study helps researchers understand how vaccines perform in real-world populations and whether they can improve protection against influenza.

Participants receive a study vaccination, attend scheduled follow-up visits, complete health assessments, and receive ongoing safety monitoring from the clinical team.

Researchers are evaluating how well the study vaccines help prevent laboratory-confirmed influenza and how the body's immune system responds after vaccination.

Participant safety is the highest priority. All Influenza vaccine clinical trials follow strict ethical, medical, and regulatory standards, with close monitoring throughout the study.

Still have questions? Our team is here to support you with your clinical research needs.
Contact Our Team

Join Us

Supporting Innovation
Through Clinical Trials

Join studies designed to advance medical knowledge and support the development of next-generation therapies.
Take the First Step Today